Delivery Order SPE2DB24D1104-SPE2DB25FXZU8
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB25FPH85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,986.43 firm fixed-price delivery order contract is for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, SPE2DB22D3004|SPE2DB25FPE79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,900.35, is a delivery order for the supply of REXULTI 1 MG TABLET 30S, a medical product, with a completion date of January 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award SPE2DB24D1007|SPE2DB25FBZTZ was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $26,261.24 firm fixed price delivery order is for the supply of 4566824777 REXULTI 0.5 MG TABLET 30S. The award has an ultimate completion date of January 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,552.53 Firm Fixed Price Delivery Order contract is for the supply of REXULTI 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,844.57 Firm Fixed Price delivery order is for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, SPE2DB22D3004|SPE2DB25FNH09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,329.06 firm fixed-price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,020.47, is a delivery order for the supply of 4565220309 REXULTI 2 MG TABLET 30S. The contract has a firm fixed price pricing type and an ultimate completion date of July 23, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,866.33 Firm Fixed Price Delivery Order contract has an ultimate completion date of December 11, 2024 and provides the REXULTI 4 MG TABLET 30S pharmaceutical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through...
This federal contract award, with an ID of SPE2DX15D3014|SPE2DX24FXDRN, is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,153.95, is for the procurement of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. This award is part of a larger...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPT45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,206.91, is a delivery order for the supply of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite...